LivaNova (LIVN) EPS (Basic) (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.79% |
| Dec 31, 2025 | 14.29% |
| Sep 30, 2025 | -2.00% |
| Jun 30, 2025 | 108.32% |
| Mar 31, 2025 | -683.50% |
| Dec 31, 2024 | 68.85% |
| Sep 30, 2024 | 103.33% |
| Jun 30, 2024 | 138.46% |
| Mar 31, 2024 | -351.61% |
| Dec 31, 2023 | 321.43% |
| Sep 30, 2023 | -800.00% |
| Jun 30, 2023 | -85.71% |
| Mar 31, 2023 | 366.67% |
| Dec 31, 2022 | 101.49% |
| Sep 30, 2022 | -748.39% |
| Jun 30, 2022 | 416.67% |
| Mar 31, 2022 | 220.00% |
| Dec 31, 2021 | 94.05% |
| Sep 30, 2021 | 26.96% |
| Jun 30, 2021 | -82.54% |
| Mar 31, 2021 | 89.19% |
| Dec 31, 2020 | -1,843.33% |
| Sep 30, 2020 | 83.43% |
| Jun 30, 2020 | -326.25% |
| Mar 31, 2020 | 300.00% |
| Dec 31, 2019 | -69.70% |
| Sep 30, 2019 | 210.00% |
| Jun 30, 2019 | -93.55% |
| Mar 31, 2019 | 92.87% |
| Dec 31, 2018 | -2,800.00% |
| Sep 30, 2018 | -148.39% |
| Jun 30, 2018 | 14.81% |
| Mar 31, 2018 | 140.91% |
| Dec 31, 2017 | -213.79% |
| Sep 30, 2017 | -38.95% |
| Jun 30, 2017 | 239.29% |
| Mar 31, 2017 | 145.16% |
| Dec 31, 2016 | -1,966.67% |
| Sep 30, 2016 | -116.67% |
| Jun 30, 2016 | 121.69% |
| Mar 31, 2016 | -82.47% |
| Oct 18, 2015 | -300.00% |
| Jul 24, 2015 | 20.00% |